Arrowhead Pharmaceuticals announces departure of Chief Commercial Officer James Hassard

ARROWHEAD PHARMACEUTICALS, INC.

James Hassard, former Chief Commercial Officer, left the company effective August 23, 2021.
No replacement or interim appointment was disclosed in the filing.
Company thanked Mr. Hassard for his service but provided no reason for departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Hassard

Chief Commercial Officer

ARWR · ARROWHEAD PHARMACEUTICALS, INC.

Effective: 2021-08-23
Filed: August 27, 2021, 7:59 PM ET

Effective August 23, 2021, James Hassard, the former Chief Commercial Officer of Arrowhead Pharmaceuticals, Inc. (the “Company”) is no longer with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James Hassard departed as Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC..

Action: left
Role: Chief Commercial Officer

Exact text from the filing

Effective August 23, 2021, James Hassard, the former Chief Commercial Officer of Arrowhead Pharmaceuticals, Inc. (the “Company”) is no longer with the Company.

View on SEC.gov

ARROWHEAD PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-21-259349

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.